Key result
Von Willebrand disease is a common bleeding disorder in the United States, with ongoing studies indicating that VWF gene polymorphisms are common and may affect laboratory assays of VWF function.
Answers are grounded in this paper and cite their sources.
Highlights the prevalence of VWD in the US and notes that VWF gene polymorphisms, common in African Americans, may affect laboratory assays.
Von Willebrand disease (VWD) is a common bleeding disorder with prevalence in the United States of 0.01 to 1% and a prevalence in the region around Milwaukee, Wisconsin, of at least 0.025%. Care of local patients with VWD primarily occurs through our comprehensive treatment centers, although some patients are managed solely by their primary care physician or community hematologist. Type 1 VWD is the most common subtype, with more females carrying this diagnosis than males. Diagnosis and treatment in general follows guidelines outlined by the National Institutes of Health. An ongoing study, the Zimmerman Program for the Molecular and Clinical Biology of VWD, is currently enrolling patients with all VWD subtypes across the United States to better delineate the extent of VWD and correlate bleeding symptoms with laboratory findings and VWF ( Von Willebrand factor) sequence variations. Results so far have shown that VWF gene polymorphisms are common, particularly in African Americans, and may affect laboratory assays of VWF function.
No takes yet. Share an insight, caveat, or question.
Flood et al. (2011) conducted a review in Von Willebrand disease (VWD). Von Willebrand disease is a common bleeding disorder in the United States, with ongoing studies indicating that VWF gene polymorphisms are common and may affect laboratory assays of VWF function.
Synapse has enriched 10 related papers. Consider them for comparative context: